Serum CC Chemokines as Potential Biomarkers for the Diagnosis of Major Depressive Disorder

References

• Li Z, Ruan M, Chen J, Fang Y. Major depressive disorder: advances in neuroscience research and translational applications. Neurosci Bull. 2021;37:863–880. doi:10.1007/s12264-021-00638-3
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang Y, Wang H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6:211–224. doi:10.1016/S2215-0366(18)30511-X
   PubMed Web of Science ®Google Scholar
• Vos T, Allen C, Arora M. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545–1602. doi:10.1016/S0140-6736(16)31678-6
   PubMed Web of Science ®Google Scholar
• Mogi T, Toda H, Yoshino A. Clinical characteristics of patients with diagnostic uncertainty of major depressive disorder. Asian J Psychiatr. 2017;30:159–162. doi:10.1016/j.ajp.2017.10.001
   PubMed Web of Science ®Google Scholar
• Chen K, Bao Z, Tang P, Gong W, Yoshimura T, Wang J. Chemokines in homeostasis and diseases. Cell Mol Immunol. 2018;15:324–334.
   PubMed Web of Science ®Google Scholar
• Leighton S, Nerurkar L, Krishnadas R, Johnman C, Graham G, Cavanagh J. Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis. Mol Psychiatry. 2018;23:48–58. doi:10.1038/mp.2017.205
   PubMed Web of Science ®Google Scholar
• Campuzano S, Yáñez-Sedeño P, Pingarrón J. Revisiting Electrochemical Biosensing in the 21st Century Society for Inflammatory Cytokines Involved in Autoimmune, Neurodegenerative, Cardiac, Viral and Cancer Diseases. Sensors. 2020;1;21.
   Google Scholar
• Wohleb E, McKim D, Sheridan J, Godbout J. Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior. Front Neurosci. 2014;8:447. doi:10.3389/fnins.2014.00447
   PubMed Web of Science ®Google Scholar
• Ślusarczyk J, Trojan E, Chwastek J, Głombik K, Basta-Kaim A, Potential A. Contribution of Chemokine Network Dysfunction to the Depressive Disorders. Curr Neuropharmacol. 2016;14:705–720. doi:10.2174/1570159x14666160219131357
   PubMed Web of Science ®Google Scholar
• Ślusarczyk J, Trojan E, Głombik K, et al. Prenatal stress is a vulnerability factor for altered morphology and biological activity of microglia cells. Front Cell Neurosci. 2015;9:82. doi:10.3389/fncel.2015.00082
   PubMed Web of Science ®Google Scholar
• Campbell S, Meier U, Mardiguian S, et al. Sickness behaviour is induced by a peripheral CXC-chemokine also expressed in multiple sclerosis and EAE. Brain Behav Immun. 2010;24:738–746. doi:10.1016/j.bbi.2010.01.011
   PubMed Web of Science ®Google Scholar
• Powell T, McGuffin P, D’Souza U, et al. Putative transcriptomic biomarkers in the inflammatory cytokine pathway differentiate major depressive disorder patients from control subjects and bipolar disorder patients. PLoS One. 2014;9:e91076. doi:10.1371/journal.pone.0091076
   PubMed Web of Science ®Google Scholar
• Simon N, McNamara K, Chow C, et al. A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol. 2008;18:230–233. doi:10.1016/j.euroneuro.2007.06.004
   PubMed Web of Science ®Google Scholar
• Grassi-Oliveira R, Brieztke E, Teixeira A, et al. Peripheral chemokine levels in women with recurrent major depression with suicidal ideation. Rev brasileira de psiquiatria. 2012;34:71–75. doi:10.1590/s1516-44462012000100013
   PubMed Web of Science ®Google Scholar
• Kiris E, Kota K, Burnett J, Soloveva V, Kane C, Bavari S. Recent developments in cell-based assays and stem cell technologies for botulinum neurotoxin research and drug discovery. Expert Rev Mol Diagn. 2014;14:153–168. doi:10.1586/14737159.2014.867808
   PubMed Web of Science ®Google Scholar
• Merendino R, Di Pasquale G, De Luca F, et al. Involvement of fractalkine and macrophage inflammatory protein-1 alpha in moderate-severe depression. Mediators Inflamm. 2004;13:205–207. doi:10.1080/09511920410001713484
   PubMed Web of Science ®Google Scholar
• Camacho-Arroyo I, Flores-Ramos M, Mancilla-Herrera I, et al. Chemokine profile in women with moderate to severe anxiety and depression during pregnancy. BMC Pregnancy Childbirth. 2021;21:807. doi:10.1186/s12884-021-04225-2
   PubMed Web of Science ®Google Scholar
• Lehto S, Niskanen L, Herzig K, et al. Serum chemokine levels in major depressive disorder. Psychoneuroendocrinology. 2010;35:226–232. doi:10.1016/j.psyneuen.2009.06.007
   PubMed Web of Science ®Google Scholar
• Ko H, Lim S. Production of macrophage inflammatory protein (MIP)-1alpha and MIP-1beta by human polymorphonuclear neutrophils stimulated with Porphyromonas endodontalis lipopolysaccharide. J Endod. 2002;28:754–757. doi:10.1097/00004770-200211000-00002
   PubMed Web of Science ®Google Scholar
• Petralia M, Mazzon E, Fagone P, et al. The cytokine network in the pathogenesis of major depressive disorder. Autoimmunity Rev. 2020;19:102504. doi:10.1016/j.autrev.2020.102504
   PubMed Web of Science ®Google Scholar
• Lee C, Giuliani F. The Role of Inflammation in Depression and Fatigue. Front Immunol. 2019;10:1696.
   PubMed Web of Science ®Google Scholar
• Zhu S, Liu M, Bennett S, Wang Z, Pfleger K, Xu J. The molecular structure and role of CCL2 (MCP-1) and C-C chemokine receptor CCR2 in skeletal biology and diseases. J Cell Physiol. 2021;236:7211–7222. doi:10.1002/jcp.30375
   PubMed Web of Science ®Google Scholar
• Piletz J, Halaris A, Iqbal O, et al. Pro-inflammatory biomakers in depression: treatment with venlafaxine. World J Biol Psychiatry. 2009;10:313–323. doi:10.3109/15622970802573246
   PubMed Web of Science ®Google Scholar
• Black C, Miller B. Meta-Analysis of Cytokines and Chemokines in Suicidality: distinguishing Suicidal Versus Nonsuicidal Patients. Biol Psychiatry. 2015;78:28–37. doi:10.1016/j.biopsych.2014.10.014
   PubMed Web of Science ®Google Scholar
• Brietzke E, Anna M, Teixeira A, Kapczinski F. Abnormalities in serum chemokine levels in euthymic patients with bipolar disorder. Brain Behav Immun. 2009;23:1079–1082. doi:10.1016/j.bbi.2009.04.008
   PubMed Web of Science ®Google Scholar
• Janelidze S, Ventorp F, Erhardt S, et al. Altered chemokine levels in the cerebrospinal fluid and plasma of suicide attempters. Psychoneuroendocrinology. 2013;38:853–862. doi:10.1016/j.psyneuen.2012.09.010
   PubMed Web of Science ®Google Scholar
• Swets J. Measuring the accuracy of diagnostic systems. Science. 1988;240:1285–1293.
   PubMed Web of Science ®Google Scholar
• Luo P, Yin P, Hua R, et al. A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma. Hepatology. 2018;67:662–675. doi:10.1002/hep.29561
   PubMed Web of Science ®Google Scholar
• Wang X, Zhou X, Dai Q, Ji B, Feng Z. The Role of Motivation in Cognitive Reappraisal for Depressed Patients. Front Hum Neurosci. 2017;11:516. doi:10.3389/fnhum.2017.00516
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62. doi:10.1136/jnnp.23.1.56
   PubMed Web of Science ®Google Scholar